IMNM
IMNM
NASDAQ · Biotechnology

Immunome Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$25.75
+0.68 (+2.71%)
As of Sep 22, 8:56 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +410.6% upside
Low Target $82.08
Average Target $131.49
High Target $141.61
Current Price $25.75
Current
$25.75
Target
$131.49
$82.08 $131.49 avg $141.61
Scenario Analysis
Bear Case
$82.08
218.8%
Low target
Base Case
$131.49
+410.6%
Avg target
Bull Case
$141.61
+449.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$30.06
-14.3% from high
52-Week Low
$8.93
+188.5% from low
50-Day SMA
$22.49
+14.5% vs SMA
200-Day SMA
$14.32
+79.8% vs SMA
RSI (14)
37.4
Neutral
Target vs 52W High
$131.49
+337.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%